SEAL @49 (99.2%) on 06-feb-2010 [ 1234567 ] using agenerase
CPL @1095 (98.4%) on 17-jan-2018 [ "effects are possible with _" "_ currently expires in" "pharmacokinetic interactions between _" "Clinical studies have not evaluated _" "_ is considered a pregnancy Category C medication" "_ is a protease inhibitor" "_ is an anti-HIV medication" "Special Warnings with _" "you are getting genuine _" "shared decision about _" "drug interactions between _" "Inhibitors Taking _" "certain drugs with _" "_ crosses the blood-brain barrier" "Overdose of _" "serious drug interactions with _" "side effects are possible with _" ] using agenerase
CPL @1111 (57.4%) on 25-jun-2018 [ "effects are possible with _" "_ currently expires in" "pharmacokinetic interactions between _" "Clinical studies have not evaluated _" "_ is considered a pregnancy Category C medication" "less side effects than _" "_ is an anti-HIV medication" "Special Warnings with _" "gastrointestinal side effects than _" "_ is used off-label" "overdosage with _" "shared decision about _" "drug interactions between _" "Inhibitors Taking _" "certain drugs with _" "Drugs such as _" "_ crosses the blood-brain barrier" "Overdose of _" "_ is a sulfa drug" "serious drug interactions with _" "side effects are possible with _" "Protease Inhibitors Taking _" ] using agenerase
MBL @526 (96.9%) on 08-mar-2012 [ Promotion of drug:agenerase drugworkedonbyagent biotechcompany:glaxosmithkline ]
SEAL @178 (93.8%) on 14-dec-2010 [ 1234 ] using agenerase